Surgery
Volume 128, Issue 1 , Pages 59-66 , July 2000

Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells

,Accepted 13 February 2000.

References 

  1. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128
  2. Mudd SH, Irreverre F, Laster L. Sulfite oxidase deficiency in men: demonstration of the enzymatic defect. Science. 1967;143:1443–1445
  3. Ueland PM, Refsum H, Harker LA, Striker GE. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med. 1989;114:473–501
  4. Malinow MR. Hyperhomocysteinemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 1990;81:2004–2006
  5. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–1057
  6. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Ann Rev Nutr. 1992;12:279–298
  7. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullman D, et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877–881
  8. Harker LA, Slichter SJ, Scott CR, Ross R. Homocysteinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537–543
  9. Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteine induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731–741
  10. Dudman NP, Wilcken DE. Homocysteine thiolactone and experimental homocysteinemia. Biochem Med. 1982;27:244–253
  11. Stamler JS, Osborne JA, Rabbani LE, Mullins M, Singel D, Loscalzo J, et al.  Adverse vascular effects of homocyst(e)ine are modulated by endothelium-derived relaxing factor and relate oxides of nitrogen. J Clin Invest. 1993;91:308–318
  12. Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NE, Tan LC, et al.  Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest. 1996;97:146–153
  13. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843–14846
  14. Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol. 1994;6:415–424
  15. Ruderman JV. MAP kinase and the activation of quiescent cells. Curr Opin Cell Biol. 1993;5:207–213
  16. Pelech SL, Sanghera JS. MAP kinases: charting the regulatory pathways. Science. 1992;257:1355–1356
  17. Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, et al.  Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem. 1997;272:25380–25385
  18. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686–7689
  19. Mills I, Cohen CR, Kamal K, Li G, Shin T, Du W, et al.  Strain activation of bovine aortic smooth muscle cell proliferation and alignment: study of strain dependency and the role of protein kinase A and C signaling pathways. J Cell Physiol. 1997;170:228–234
  20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 1970;227:680–685
  22. Towbin H, Staehlin T, Gorden J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci U S A. 1979;76:4350–4354
  23. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al.  Promotion of vascular smooth muscle cell growth by homocyteine: a link to atherosclerosis. Proc Nat Acad Sci U S A. 1994;91:6369–6373
  24. Dalton ML, Gadson PF, Wrenn RW, Rosenquist TH. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB. 1997;11:703–711
  25. Dudrick SJ. Regression of atherosclerosis by the intravenous infusion of specific biochemical nutrient substrates in animals and human. Ann Surg. 1987;206:296–315
  26. Wilken DE, Dudman NP. Mechanisms of thrombogenesis and accelerated atherogenesis in homocysteinaemia. Haemostasis. 1989;19:14–23
  27. Dudman NP, Hicks C, Wang J, Wilcken DE. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis. 1991;91:77–83
  28. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113–121
  29. Ewadh MJ, Tudball N, Rose FA. Homocysteine uptake by human umbilical vein endothelial cells in culture. Biochim Biophys Acta. 1990;1054:263–266
  30. Ikeda M, Takei T, Mills I, Sumpio BE. Calcium-independent activation of extracellular signal regulated kinases 1 and 2 by cyclic strain. Biochem Biophys Res Com. 1998;247:462–465
  31. Ikeda M, Takei T, Mills I, Kito H, Sumpio BE. Extracellular signal-regulated kinases 1 and 2 activation in endothelial cells exposed to cyclic strain. Am J Physiol. 1999;276:H614–H622
  32. James NL, Harrison DG, Nerem RM. Effects of shear on endothelial cell calcium in the presence and absence of ATP. FASEB. 1995;9:968–973
  33. Pearce MJ, McIntyre TM, Prescott SM, Zimmerman GA, Whatley RE. Shear stress activates cytosolic phospholipase A2 (cPLA2) and MAP kinase in human endothelial cells. Biochem Biophys Res Comm. 1996;218:500–504
  34. Tseng H, Peterson TE, Berk BC. Fluid shear stress stimulates mitogen activated protein kinase in endothelial cells. Circ Res. 1995;77:869–878
  35. Meloche S, Seuwen K, Pages G, Pouyssegur J. Biphasic and synergistic activation of p4(ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol. 1992;6:845–854

☆ Supported by grants to B. E. S. from the National Institutes of Health (R01-47345), the Veterans Administration Merit Review Board, and the American Heart Association (National).

☆☆ Reprint requests: Bauer E. Sumpio, MD, PhD, Department of Vascular Surgery, Yale University School of Medicine, FMB 137, 333 Cedar St, New Haven, CT 06510.

PII: S0039-6060(00)98856-1

doi: 10.1067/msy.2000.106531

Surgery
Volume 128, Issue 1 , Pages 59-66 , July 2000

Article Tools

* Image Usage & Resolution